Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - October 2014

COPD: Novel Therapeutics and Management

20 Oct 2014 - 21 Oct 2014 - London, UK

Bookmark and Share

SMi is proud to present its 6th annual conference on COPD taking place from the 20th - 21st October 2014 in Central London. 

With the global COPD market forecasted to reach a value of $15.6 billion by 2019, COPD 2014 comes at a perfect time to provide the industry with a niche platform for discussion and a forum to learn from key visionaries in the field of COPD. 

The latest instalment in the successful series has evolved to include topical and current sessions, such as Patient Care and The Future of COPD, as well as presenting attendees with in-depth information on exacerbation and comorbidities, ensuring a successful clinical trial design and challenges in drug development and market access. 

“Fast and cost effective development of drugs that help to improve significantly the quality of life of patients requires the intensified collaboration of industry, academia, clinical research and regulators agencies. Working in the field of biomarkers at the interface of pre-clinical and clinical research makes this an everyday requirement. The 6th COPD conference will bring together key opinion leaders from different stakeholders and will therefore foster this collaboration, especially by providing a very focused agenda.” Thomas Schlange, Senior Biomarker Expert, Bayer


  • Marcello Milano, Executive Global Regulatory Affairs, Chiesi
  • Thomas Schlange, Senior Biomarker Expert, Bayer
  • Mercedes Prior, Head of Global Market Access, Almirall
  • Carla Bauer, Investigator, Novartis
  • Jan-Anders Karlsson, CEO, Verona Pharma
  • Ewan Walters, Medical Director, Teva
  • Rosa Lamarca, Head of Clinical Statistics, Almirall
  • Robert Wilson, Consultant Physician Lung Division, Royal Brompton Hospital
  • Abebaw Yohannes, Reader in Physiotherapy, Manchester Metropolitan University
  • Jim & Mary Nelson, Patient, Caregiver, Representatives of COPD Foundation and EFFORTS Online Support Group


  • Understand the regulatory aspects of COPD, both from regulatory bodies and the industry
  • Examine the current challenges to modelling exacerbations in COPD using animal models
  • Evaluate COPD and comorbidities
  • Understand the link between COPD and anxiety and depression
  • Review the challenges in clinical trial designs and in drug development
  • Discover the importance of putting the patient at the centre of everything
  • Gain insight from real life story of a lung transplant patient

To register or to download a brochure, visit

Alternatively contact Fateja Begum on +44 (0) 207 827 6184 or email 

Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
The Power Of Orthogonality In Assessing The Stability Of Biopharmaceuticals
By utilizing orthogonal techniques, researchers can maximize the secure application of all analytical results generated.
Dysfunction in Neuronal Transport Mechanism Linked to Alzheimer’s
Findings confirm mutation-caused problem but also reveal a new therapeutic target.
New Antibody Therapy Permanently Blocks SIV Infection
An international research team has developed an effective treatment strategy against the HIV-like Simian Immunodeficiency Virus (SIV) in rhesus macaques.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
DNA Vaccines Protect Monkeys Against Zika Virus
Two experimental Zika virus DNA vaccines developed by NIH scientists protected monkeys against Zika infection.
Rare Flu-Thwarting Mutation Discovered
Study finds protein mutation, that is encoded by influenza, causes the virus to lose any defence against the immune system.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos